反応 #792876
ord-ffcf65b0e67a4288a541c122a85c47cc
反応方程式
反応物
試薬
反応条件
後処理
- 1抽出The aqueous layer was extracted with dichloromethane (6×100 mL)
- 2乾燥dried over magnesium sulfate
- 3ろ過filtered through a fritted glass
- 4ろ過filter
- 5その他evaporated to dryness
- 6workup.DISSOLUTIONThe solid residue was dissolved in 6 mL of methanol
- 7workup.ADDITION23 mL of acetonitrile were added
- 8その他An oily residue that formed
- 9その他was decanted away from and
- 10その他dried under vacuum
- 11workup.DISSOLUTIONThe crude solid was dissolved into a minimal amount of boiling methanol (40 mL)
- 12workup.ADDITIONacetonitrile (100 mL, 2.5:1, acetonitrile to methanol ratio) was added
実験手順
5-(3-Azabicyclo[3.1.0]hexan-1-yl)-3-methyl-1,2,4-oxadiazole (105) (923 mg, 4.58 mmol) was dissolved in water (20 mL) and treated with saturated sodium bicarbonate (40 mL), and 5 g of sodium chloride (pH8). The aqueous layer was extracted with dichloromethane (6×100 mL), the organic layers combined, dried over magnesium sulfate and filtered through a fritted glass filter. The filtrate was treated with D-tartaric acid (655 g, 4.36 mmol) in 60 mL of methanol and evaporated to dryness. The solid residue was dissolved in 6 mL of methanol and then 23 mL of acetonitrile were added. An oily residue that formed was decanted away from and dried under vacuum. The crude solid was dissolved into a minimal amount of boiling methanol (40 mL) and then acetonitrile (100 mL, 2.5:1, acetonitrile to methanol ratio) was added. The mixture was allowed to stir at room temperature for 20 minutes prior to isolation. The process was repeated until the crystalline substance exceeded an enantiomeric purity of 99.5°; obtained 440 mg of 5-((1S,5S)-3-azabicyclo[3.1.0]hexan-1-yl)-3-methyl-1,2,4-oxadiazole (106b). The optical purity was determined by HPLC analysis (Chiral Technologies Chiral-AGP, 4.0 mm×150 mm, 0.5% methanol 20 mM sodium phosphate pH=7). (106b) MS (ESI) m/z 165.8 [M+H]+. 1H NMR (DMSO-d6) δ: 1.44 (m, 2H), 2.23 (m, 1H), 2.28 (s, 3H), 3.06 (s, 2H), 3.35 (m, 2H), 4.13 (s, 2H).